TrialCancer science2014

Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).

Shuichi Hironaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.